293例哮喘患儿变应原分析

徐孝华, 杭杲

徐孝华, 杭杲. 293例哮喘患儿变应原分析[J]. 实用临床医药杂志, 2006, (7): 119-120. DOI: 10.3969/j.issn.1672-2353.2006.07.055
引用本文: 徐孝华, 杭杲. 293例哮喘患儿变应原分析[J]. 实用临床医药杂志, 2006, (7): 119-120. DOI: 10.3969/j.issn.1672-2353.2006.07.055

293例哮喘患儿变应原分析

详细信息
  • 中图分类号: R562.2

  • 摘要: 哮喘是一种气道慢性炎症性疾病,基础为气道的高反应性.变应原是诱发哮喘发作的原因之一,为了对本地区哮喘患儿诱发发作的变异原有更大程度的了解,对本院门诊的203例哮喘患儿进行了22种常见变应原浸液皮肤点刺实验,结果报告如下.
  • 全国儿科哮喘协作组. 儿童哮喘防治常规(试行) [J]. 中华儿科杂志, 1998, (12):747.doi: 10.3760/j.issn:0578-1310.1998.12.014.
    文昭明. 变态反应性疾病的诊治 [M]. 北京:中国医药科技出版社, 1997.78.
    杜永成. 哮喘的现代诊断与治疗 [M]. 北京:中国医药科技出版社, 2002.5.
    Hill D, Hosking C, Reyes-Benito L. Reducing the need for food allergen challenges in young children:a comparison of in vitro with in vivo tests [J]. Vaccine, 2001, (32):4588.doi: 10.1016/S0264-410X(01)00257-2.
    于陆, 赖乃揆. 支气管哮喘的体内、体外检测和免疫治疗的相关分析 [J]. 中华微生物学和免疫学杂志, 2001(4):87.
    陈琳, 贾战生, 林永信. 血清IgE水平检测及变应原皮试诊断Ⅰ型变态反应性疾病的意义 [J]. 第四军医大学学报, 2001(4):344.doi: 10.3321/j.issn:1000-2790.2001.04.016.
    Host A, Halken S. The role of allergy in childhood asthma [J]. ALLERGY, 2000.600.doi: 10.1034/j.1398-9995.2000.00122.x.
    Graham A W, Martinelli R, Brunet L R. Innate immune responses to mycobacteria and the downregulation of atopic responses [J]. Journal of Allergy and Clinical Immunology, 2003(5):337.
    Wamar J. Materoetal interaction and allergy [J]. ALLERGY, 1996.447.
    Malling H J. Immunotherapy as an effective tool in allergy treatment [J]. Allergy, 1998.461.doi: 10.1111/j.1398-9995.1998.tb04082.x.
    Passalacqua G, Bagnasco M, Mariani G. Local immunotherapy:pharmacokinetics and efficacy [J]. Allergy, 1998.477.doi: 10.1111/j.1398-9995.1998.tb04084.x.
    Oliver C, Roland S, Helga K. Transition of recombinant allergens from bench to clinical application [J]. Methods:A Companion to Methods in Enzymology, 2004.300.
    Oldfield W L G, Larehe I V L, Kay A B. Effect of T-cell peptides derived from Fel d1 on allergic reactions and cytokine production in patients sensitive to cats:a randomised controlled tria1 [J]. Lancet, 2002.47.
    Mahler V, Vrtala S, Kuss O. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet vl [J]. Clinical and Experimental Allergy, 2004(1):115.doi: 10.1111/j.1365-2222.2004.01857.x.
计量
  • 文章访问数:  103
  • HTML全文浏览量:  10
  • PDF下载量:  3
  • 被引次数: 0
出版历程
  • 发布日期:  2006-09-10

目录

    /

    返回文章
    返回
    x 关闭 永久关闭